Quoted By:
FDA Vaccine Advisors Discuss Waning Efficacy of Boosters, Ignore Pleas by Vaccine-Injured
April 8, 2022 0
by Madhava Setty, M.D., Childrens Health Defense:
The U.S. Food and Drug Administration’s (FDA) vaccine advisory panel met Wednesday to discuss the topic of a second booster dose of COVID-19 vaccines for the American public.
After nine-and-a-half hours, the Vaccines and Related Biological Products Advisory Committee (VRBPAC) failed to reach a consensus, even though last week — despite a paucity of data — the agency authorized a second booster dose for people over age 50 and the immunocompromised.
The committee did not discuss Emergency Use Authorization or approval of COVID vaccines for children or infants.
